Stonewise Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 11

Stonewise General Information

Description

Manufacturer of an artificial intelligence drug discovery system designed to accelerate and improve the early stages of pharmaceutical development. The company offers integrated AI-driven capabilities such as pocket finding, molecular generation, ultra-high throughput virtual screening, rational design, and druggability optimisation, enabling pharmaceutical researchers and biopharmaceutical companies to advance from hit identification to preclinical candidate optimisation with greater speed and efficiency.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10th Floor, Block A, Sinosteel Plaza
  • Number 8 Haidian Street, Haidian District, Beijing
  • Beijing, 100080
  • China
+86 010
Primary Industry
Drug Discovery
Corporate Office
  • 10th Floor, Block A, Sinosteel Plaza
  • Number 8 Haidian Street, Haidian District, Beijing
  • Beijing, 100080
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stonewise Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 01-Jan-2026 Completed Generating Revenue
4. Early Stage VC (Series B1) 12-Apr-2021 Completed Generating Revenue
3. Early Stage VC (Series A1) 09-Sep-2020 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Mar-2020 $10M $10M Completed Generating Revenue
1. Seed Round 23-Jul-2019 Completed Startup
To view Stonewise’s complete valuation and funding history, request access »

Stonewise Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of an artificial intelligence drug discovery system designed to accelerate and improve the early stages of
Drug Discovery
Beijing, China

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Stonewise Competitors (1)

One of Stonewise’s competitors is Numerion Labs, a Venture Capital-Backed company based in San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Numerion Labs Venture Capital-Backed San Francisco, CA
You’re viewing 1 of 1 competitors. Get the full list »

Stonewise Patents

Stonewise Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026061487-A1 Molecular prediction model training method and protein pocket processing method Pending 20-Sep-2024
WO-2023226679-A1 3c-like protease inhibitor Inactive 27-May-2022
WO-2023227117-A1 3c-like protease inhibitor Inactive 27-May-2022
WO-2023227118-A1 3c-like protease inhibitor Inactive 27-May-2022

Stonewise Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Soul Capital (China) Venture Capital Minority
Xiang He Capital Venture Capital Minority
CDH Investments PE/Buyout Minority
Eastern Bell Venture Capital Venture Capital Minority
Greater Bay Area Homeland Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Stonewise FAQs

  • When was Stonewise founded?

    Stonewise was founded in 2018.

  • Where is Stonewise headquartered?

    Stonewise is headquartered in Beijing, China.

  • What industry is Stonewise in?

    Stonewise’s primary industry is Drug Discovery.

  • Is Stonewise a private or public company?

    Stonewise is a Private company.

  • What is Stonewise’s current revenue?

    The current revenue for Stonewise is .

  • How much funding has Stonewise raised over time?

    Stonewise has raised $50M.

  • Who are Stonewise’s investors?

    Soul Capital (China), Xiang He Capital, CDH Investments, Eastern Bell Venture Capital, and Greater Bay Area Homeland are 5 of 11 investors who have invested in Stonewise.

  • Who are Stonewise’s competitors?

    Numerion Labs is a competitor of Stonewise.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process